Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.50    -1.50 (-3.13%)
Bid:
46.00
Ask:
47.00
Spread: 1.00 (2.174%)
Market Cap: £42.63m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q1 Trading Update

24 Sep 2025 07:01

RNS Number : 4899A
Time Finance PLC
24 September 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

24 September 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Q1 Trading Update

 

Record Quarterly Revenues, Record Net Tangible Assets and Record Lending Book

 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to provide the following update on the Group's trading performance for the first quarter of the current financial year covering the three months to 31 August 2025. The results reflect the continued strong demand for the Group's multi-product funding offering which has resulted in further growth across all key financial metrics. The lending book has now enjoyed seventeen consecutive quarters of growth, while the Group's continued lending discipline has delivered unchanged levels of arrears and write-offs.

 

Unaudited Q1 2025/26 financial highlights:

· Own-Book Lending Origination up 30% to £28.5m (Q1 2024/25: £22.0m)

· Revenue up 3% to £9.4m (Q1 2024/25: £9.1m)

· Profit before Tax up 11% to £2.1m (Q1 2024/25: £1.9m)

· Profit Before Tax margin up 100 bps to 22% (Q1 2024/25: 21%)

· Net Tangible Assets up 14% to £45.6m at 31 August 2025 (31 August 2024: £40.1m)

· Gross Lending Book up 8% to £221.1m at 31 August 2025 (31 August 2024: £205.3m)

· Net Arrears unchanged at 5% of the gross lending book at 31 August 2025 (31 August 2024: 5%)

· Net Bad Debt Write-Offs unchanged at 1% of the average gross lending book at 31 August 2025 (31 August 2024: 1%)

 

As targeted in the Company's three-year strategic plan through to May 2028 that was launched in January 2025, the Group's focus on secured lending through its Invoice Finance division and the 'Hard' subset of the wider Asset division has continued. These two product sets now account for approximately 85% of the entire lending book, up from 76% twelve months earlier. They have also accounted for over 95% of all new deals written in the first quarter of this financial year.

 

Ed Rimmer, Chief Executive Officer commented:

"As we enter the first year of our new three-year medium-term strategic plan, I am very encouraged that the initial quarter has continued to deliver increased growth in our lending book; a strengthened Balance Sheet with increased Net Tangible Assets; and record quarterly Revenues and Profit Before Tax. The lending book has now seen consistent increases for seventeen consecutive quarters, reflecting the demand for our multi-product offering and the value that is placed on our first-class customer service by UK businesses seeking access to finance. Net arrears and Net Bad Debt write-offs also continue to be well within our target ranges and underline our commitment to responsible and sustainable lending. The Board, therefore, retains confidence that the Group is positioned for further growth and will build increased value for its shareholders over time."

 

Outlook

The Board confirms that it continues to expect the Group's trading for the current financial year ending 31 May 2026 to be at least in line with market expectations.

 

 

Notice of Investor Presentation

As previously announced, the Company will deliver a live presentation relating to this trading update and the simultaneously released FY 2024/25 audited annual results announcement via the Group's investor website at 1pm BST today. The presentation is open to all existing and potential shareholders who can sign up via: https://investors.timefinance.com/webinars/oPB5mr-fy-results-2024-2025-webinar.

 

For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.

 

Ends

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

 

 

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEMFEDEISEIU
Date   Source Headline
15th Nov 202312:54 pmRNSChange of Nominated Adviser & Corporate Broker
9th Nov 20237:00 amRNSTrading Update
7th Nov 202311:45 amRNSResult of AGM
23rd Oct 20238:30 amRNSDirector Share Purchase
19th Oct 20237:00 amRNSDirector Share Purchase
11th Oct 20237:00 amRNSDirector Share Purchases
3rd Oct 20237:00 amRNSDirector/PDMR Shareholdings: Vesting of Options
27th Sep 20238:30 amRNSNotice of AGM
26th Sep 20237:00 amRNSQ1 Trading Update
26th Sep 20237:00 amRNSFinal Results
19th Sep 20237:00 amRNSAppointment of Independent Non-Executive Directors
12th Sep 20237:00 amRNSOwn-Book Update, Notice of Results, Pres & AGM
11th Jul 20237:00 amRNSDirector Share Purchase
29th Jun 20237:00 amRNSFull Year Trading Update
24th May 20239:04 amRNSDelivery of First Asset-Based Lending Facility
3rd May 20237:00 amRNSTrading Update & Notice of Final Results
8th Mar 20237:00 amRNSQ3 Trading Update: Pre-Tax Profits up 172%
9th Feb 202311:40 amRNSHolding in Company
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSInterim Results
20th Dec 20221:24 pmRNSExercise of Options & Director/PDMR Shareholding
16th Dec 20227:00 amRNSH1 Trading Update & Notice of Interim Results
14th Nov 20227:00 amRNSDirector Share Purchases
3rd Nov 20227:00 amRNSMelloLondon Investor Conference
31st Oct 20222:00 pmRNSResult of AGM
19th Oct 20227:00 amRNSOwn Book Lending Portfolio reaches record £145m
5th Oct 20227:00 amRNSDirector Share Purchase
4th Oct 202212:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:15 pmRNSNotice of AGM
22nd Sep 20227:00 amRNSQ1 Trading Update
22nd Sep 20227:00 amRNSFinal Results for the year ended 31 May 2022
15th Sep 20227:00 amRNSNotice of Results & Q1 Update and Presentation
6th Sep 20227:00 amRNSAppointments Strengthen Asset Finance Division
22nd Jul 20227:00 amRNSNew LTIP & Director/PDMR Shareholding
19th Jul 20227:02 amRNSDirector Share Purchases
18th Jul 20227:00 amRNSDirector Share Purchase
7th Jul 20227:00 amRNSTrading Update & Notice of Final Results
10th Jun 20227:00 amRNSNotice of Trading Update and Investor Presentation
5th May 20229:19 amRNSHolding in Company
27th Apr 20223:28 pmRNSHolding in Company
27th Apr 202212:51 pmRNSHolding in Company
26th Apr 20223:30 pmRNSTR-1 Holding in Company
26th Apr 20229:36 amRNSTR-1 Holding in Company
14th Feb 202210:00 amRNSExercise of Options & Director/PDMR Shareholdings
20th Jan 20227:00 amRNSInterim Results
5th Jan 20227:00 amRNSNotice of Interim Results Investor Presentation
15th Dec 20217:00 amRNSH1 Trading Update & Notice of Interim Results
21st Oct 20213:40 pmRNSResult of AGM & Directorate Change
1st Oct 20217:00 amRNSVesting of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.